Skip to content

Clinical trials

Phase 3 Rheumatic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rheumatic Diseases Phase: Phase 3 Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20081
20094
20102
20112
20131
20141
20152
20161
20201
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Regeneron Pharmaceuticals4
Novartis Pharmaceuticals2
Organogenesis2
Pfizer2
Tonix Pharmaceuticals, Inc.2
Amgen1
Biocad1
Janssen Research & Development, LLC1
Mabion SA1
McGill University Health Centre/Research Institute of the McGill University Health Centre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rheumatic Diseases19
Arthritis11
Joint Diseases11
Musculoskeletal Diseases10
Arthritis, Rheumatoid6
Gout6
Genetic Diseases, Inborn4
Metabolic Diseases4
Metabolism, Inborn Errors4
Osteoarthritis4

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.